title: Recovery after copper-deficiency myeloneuropathy in Wilson's disease.
authors.forename: Tiago
authors.initials: T
authors.lastname: Teodoro
authors.forename: Dulce
authors.initials: D
authors.lastname: Neutel
authors.forename: Patrícia
authors.initials: P
authors.lastname: Lobo
authors.forename: Ana F
authors.initials: AF
authors.lastname: Geraldo
authors.forename: Isabel
authors.initials: I
authors.lastname: Conceição
authors.forename: Mário M
authors.initials: MM
authors.lastname: Rosa
authors.forename: Luísa
authors.initials: L
authors.lastname: Albuquerque
authors.forename: Joaquim J
authors.initials: JJ
authors.lastname: Ferreira
mesh_terms: D000328:Adult; D003300:Copper / Q000172:deficiency* / Q000378:metabolism; D003677:Deficiency Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D013116:Spinal Cord / Q000473:pathology; D013118:Spinal Cord Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D014266:Trientine / Q000009:adverse effects / Q000627:therapeutic use; D019287:Zinc Sulfate / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D019287:Zinc Sulfate; D003300:Copper; D014266:Trientine